Treatment failure in erythema migrans--a review
- PMID: 8852475
- DOI: 10.1007/BF01780663
Treatment failure in erythema migrans--a review
Abstract
Patients with erythema migrans can fail to respond to antibiotic therapy. Persistent or recurrent erythema migrans, major sequelae such as meningitis and arthritis, survival of Borrelia burgdorferi and significant and persistent increase of antibody titres against B. burgdorferi after antibiotic therapy are strong indications of a treatment failure. Most, if not all, antibiotics used so far have been associated with a treatment failure in patients with erythema migrans. Roxithromycin and erythromycin are definitely or probably ineffective. However, doxycycline, amoxicillin, cefuroxime, ceftriaxone, azithromycin and high-dose penicillin V perform comparably well.
Similar articles
-
Solitary erythema migrans: a clinical, laboratory and epidemiological study of 77 Dutch patients.Br J Dermatol. 1994 Apr;130(4):466-72. doi: 10.1111/j.1365-2133.1994.tb03379.x. Br J Dermatol. 1994. PMID: 8186111
-
Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings.Infection. 1993 Mar-Apr;21(2):83-8. doi: 10.1007/BF01710737. Infection. 1993. PMID: 8387966 Clinical Trial.
-
Persistence of Borrelia burgdorferi sensu lato in resolved erythema migrans lesions.Clin Infect Dis. 1995 Aug;21(2):380-9. doi: 10.1093/clinids/21.2.380. Clin Infect Dis. 1995. PMID: 8562748
-
Lyme disease.Semin Dermatol. 1993 Dec;12(4):357-62. Semin Dermatol. 1993. PMID: 8312152 Review.
-
Early disseminated borreliosis with multiple erythema migrans and elevated liver enzymes: case report and literature review.Acta Derm Venereol. 2007;87(5):418-21. doi: 10.2340/00015555-0267. Acta Derm Venereol. 2007. PMID: 17721649 Review.
Cited by
-
Borreliella burgdorferi Antimicrobial-Tolerant Persistence in Lyme Disease and Posttreatment Lyme Disease Syndromes.mBio. 2022 Jun 28;13(3):e0344021. doi: 10.1128/mbio.03440-21. Epub 2022 Apr 25. mBio. 2022. PMID: 35467428 Free PMC article. Review.
-
The In Vitro Antimicrobial Susceptibility of Borrelia burgdorferi sensu lato: Shedding Light on the Known Unknowns.Pathogens. 2023 Sep 28;12(10):1204. doi: 10.3390/pathogens12101204. Pathogens. 2023. PMID: 37887720 Free PMC article. Review.
-
Lyme borreliosis--an overdiagnosed disease?Infection. 1997 May-Jun;25(3):140-3. doi: 10.1007/BF02113600. Infection. 1997. PMID: 9181379
-
PCR-Based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-Day postinfection period.J Clin Microbiol. 2000 Jun;38(6):2191-9. doi: 10.1128/JCM.38.6.2191-2199.2000. J Clin Microbiol. 2000. PMID: 10834975 Free PMC article.
-
Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society.Ger Med Sci. 2017 Sep 5;15:Doc14. doi: 10.3205/000255. eCollection 2017. Ger Med Sci. 2017. PMID: 28943834 Free PMC article.